Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Limits how much Medicare Part D drug premiums can increase each year.
The problem
Medicare Part D prescription drug premiums rise significantly each year, making medications less affordable for older adults and disabled people who depend on these benefits.
The proposal
The bill would cap the annual increases in Part D premiums to protect beneficiaries from large year-to-year price jumps on their drug coverage.
The impact
Seniors and disabled Medicare beneficiaries would pay more predictable drug insurance costs. Insurance companies and pharmaceutical manufacturers might face reduced revenues from premium constraints.
Older adults on fixed incomes would have more predictable healthcare costs. Premium caps help people afford both medications and other necessities. Lower out-of-pocket expenses reduce financial stress.
People could plan their finances better with limited premium increases. Predictable costs reduce uncertainty and help with household budgeting. Seniors can make better decisions about their coverage.
Disabled individuals and low-income seniors benefit most from premium protections. Those living on fixed incomes cannot easily absorb large increases. The policy directly helps people who struggle most with healthcare costs.
Medicare Advantage and Part D insurers would collect less in premiums each year. Companies might respond by reducing coverage or benefits. Fewer insurers might participate in Medicare programs.
Insurers facing premium caps might eliminate drug plans or reduce pharmacy networks. Beneficiaries could have fewer plan choices available to them. Competition between insurers might decrease.
If insurers cannot raise premiums, they might increase deductibles or copays instead. Beneficiaries could pay more when they actually fill prescriptions. The overall cost burden might not actually decrease.
Medicare subsidies might need to increase to support insurers offering plans at capped premiums. Taxpayers could bear higher costs for the program. The bill's actual fiscal impact is unclear without more details.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.